OXT and eating disorder: These convergent associations support the validity of our phenotype classifications and confirm that the measured constructs behave as theoretically expected—oxytocin levels decline, leptin and metabolic-risk indices rise, and eating-disorder symptomatology intensifies across worsening metabolic states.